ONCOCLÍNICAS APPROVES A CAPITAL INCREASE OF R$1.5 BILLION
Sao Paulo (ots/PRNewswire) – The aim of the operation is to strengthen the company’s financial position and maintain its growth strategy Oncoclinics&Co (B3: ONCO3)a leading oncology company headquartered in Latin…